Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNPH1 | O43598 | 1/20 | 0.46 |
| ▸ | UMPS | P11172 | 3/20 | 0.44 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.41 |
| ▸ | TYMS | P04818 | 2/20 | 0.40 |
| ▸ | TK1 | P04183 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31725092 | 0.93 | P2RY6 (0.45) | P2RY6 | |
| SCHEMBL26883186 | 0.91 | P2RY2 (0.48) | P2RY6 | |
| SCHEMBL31381448 | 0.91 | P2RY2 (0.48) | P2RY6 | |
| SCHEMBL26883180 | 0.91 | P2RY2 (0.48) | P2RY6 | |
| SCHEMBL18118158 | 0.87 | DNPH1 (0.53) | DNPH1UMPSP2RY6 | |
| SCHEMBL17789097 | 0.87 | DNPH1 (0.53) | DNPH1UMPSP2RY6 | |
| SCHEMBL17809088 | 0.87 | DNPH1 (0.53) | DNPH1UMPSP2RY6 | |
| SCHEMBL14929195 | 0.87 | DNPH1 (0.53) | DNPH1UMPSP2RY6 | |
| SCHEMBL15836223 | 0.87 | DNPH1 (0.53) | DNPH1UMPSP2RY6 | |
| SCHEMBL10133476 | 0.87 | DNPH1 (0.53) | DNPH1UMPSP2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346888-A1 | PROMOTER PROXIMAL SEQUENCES AND USES THEREOF FOR RNA MANUFACTURING | HELIX NANOTECHNOLOGIES INC (US) | 2025-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346888-A1 | PROMOTER PROXIMAL SEQUENCES AND USES THEREOF FOR RNA MANUFACTURING | RNGTT, NSUN2, CPSF6 | DNPH1 2996/4885UMPS 225/4885P2RY6 3990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.